Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LQDA Liquidia Technologies Inc

盘前交易 10-05 04:29:55 EDT

28.64

+0.65

+2.32%

盘前28.64

+0.000.00%

04:11 EDT

最高29.18	最低26.31	成交量840.41万
今开26.69	昨收27.99	日振幅10.25%
总市值25.64亿	流通市值20.30亿	总股本8,951万
成交额2.37亿	换手率11.86%	流通股本7,089万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":28.64,"timestamp":1790971200000,"preClose":27.99,"halted":0,"volume":8404136,"hourTrading":{"tag":"盘前","latestPrice":28.64,"preClose":28.64,"latestTime":"04:11 EDT","volume":1316,"amount":37463.278692,"timestamp":1791187896609,"change":0,"changeRate":0,"amplitude":0.008729},"delay":0,"changeRate":0.023222579492676032,"floatShares":70888363,"shares":89508891,"eps":1.4,"marketStatus":"盘前交易","change":0.65,"latestTime":"10-05 04:29:55 EDT","open":26.69,"high":29.1794,"low":26.31,"amount":237087752.84251198,"amplitude":0.102515,"askPrice":28.97,"askSize":19,"bidPrice":28.07,"bidSize":9,"shortable":3,"etf":0,"ttmEps":1.4,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791207000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":28.64,"preHourTrading":{"tag":"盘前","latestPrice":28.64,"preClose":28.64,"latestTime":"04:11 EDT","volume":1316,"amount":37463.278692,"timestamp":1791187896609,"change":0,"changeRate":0,"amplitude":0.008729},"postHourTrading":{"tag":"盘后","latestPrice":28.59,"preClose":28.64,"latestTime":"19:59 EDT","volume":62583,"amount":1785922.9977,"timestamp":1790985574630,"change":-0.05,"changeRate":-0.001746,"amplitude":0.014665},"volumeRatio":0.8711925541657713,"impliedVol":1.3143,"impliedVolPercentile":0.652},"requestUrl":"/m/hq/s/LQDA/wiki","defaultTab":"wiki","newsList":[{"id":"1100610899","title":"异动解读｜Liquidia Technologies盘中下跌45.41%，专利诉讼败诉重创市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1100610899","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100610899?lang=zh_cn&edition=full","pubTime":"2026-10-01 02:11","pubTimestamp":1790791872,"startTime":"0","endTime":"0","summary":"10月1日，Liquidia Technologies盘中下跌45.41%，报38.69美元/股，成交额3.97亿美元。该裁决意味着Liquidia核心产品YUTREPIA可能面临专利侵权赔偿或上市限制风险，对公司商业化前景构成重大不确定性。此次专利败诉判决直接冲击了市场对其持续放量增长的预期。Liquidia Corporation是一家生物制药公司，专注于肺动脉高压治疗领域，依托专有PRINT粒子工程技术平台进行药物研发与制造。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"专利败诉重创信心，股价盘中跳水","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192786112","title":"Liquidia公司Re-Warm研究预计2026年10月启动，主要阶段将于2027年2月收官","url":"https://stock-news.laohu8.com/highlight/detail?id=1192786112","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192786112?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:31","pubTimestamp":1788435071,"startTime":"0","endTime":"0","summary":"Liquidia公司宣布，其Re-Warm研究项目计划于2026年10月正式启动。该研究的主要阶段预计在2027年2月完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184500619","title":"异动解读｜Liquidia Technologies盘中下跌5.1%，Q2每股收益不及预期延续获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1184500619","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184500619?lang=zh_cn&edition=full","pubTime":"2026-08-18 23:03","pubTimestamp":1787065409,"startTime":"0","endTime":"0","summary":"8月18日，Liquidia Technologies盘中下跌5.1%，报73.74美元/股，成交额1996.73万美元，延续财报发布后的回调走势。消息面上，公司于8月12日发布Q2财报，每股收益0.74美元，低于FactSet预期的0.76美元；营收1.717亿美元，同比大幅增长，超出市场预期的1.685亿美元。核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人。尽管营收端持续放量，但EPS未达部分机构预期，叠加公司股价年内涨幅已超一倍，市场获利回吐情绪持续释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197326088","title":"异动解读｜Liquidia Technologies盘中上涨5.18%，Q2营收大幅超预期下连跌后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1197326088","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197326088?lang=zh_cn&edition=full","pubTime":"2026-08-14 23:03","pubTimestamp":1786719801,"startTime":"0","endTime":"0","summary":"8月14日，Liquidia Technologies盘中上涨5.18%，报75.84美元/股，成交额5809.96万美元。消息面上，公司于8月12日发布Q2财报，营收1.717亿美元同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人，营收超出市场预期的1.685亿美元；但每股收益0.74美元略低于FactSet预期的0.76美元。此前因EPS未达预期叠加年内涨幅已超一倍，股价在前两个交易日累计回调超10%。美银证券此前将公司评级下调至\"中性\"，目标价79美元，当前股价仍低于该目标价水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193199356","title":"异动解读｜Liquidia Technologies盘中下跌5.06%，Q2每股收益不及预期延续获利回吐压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193199356","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193199356?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:14","pubTimestamp":1786641293,"startTime":"0","endTime":"0","summary":"8月14日，Liquidia Technologies盘中下跌5.06%，报74.8美元/股，成交额1.46亿美元，延续前一交易日跌势。消息面上，公司于8月12日盘前发布第二季度财报，Q2每股收益为0.74美元，低于FactSet预期的0.76美元；营收1.717亿美元，同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人，营收超出市场一致预期的1.685亿美元。尽管营收端表现亮眼，但EPS未达部分机构预期，叠加此前公司股价年内涨幅已超一倍，市场获利回吐情绪浓厚。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146449266","title":"异动解读 | Liquidia Technologies盘中大跌5.81%，Q2每股收益不及预期引发获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1146449266","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146449266?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:40","pubTimestamp":1786552857,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc（LQDA）今日盘中大幅下挫5.81%，引发市场广泛关注。消息面上，公司于盘前发布第二季度财报。尽管营收同比增长约18.5倍至17.17亿美元，核心产品YUTREPIA净销售额达17.04亿美元，均超出市场预期，但每股收益为0.74美元，低于FactSet预期的0.76美元及LSEG汇总的0.7722美元预期。净利润亦未达部分分析师预测。此前公司股价年内涨幅已超过一倍，市场已充分消化高增长预期。在EPS不及预期的情况下，投资者选择获利了结。此外，美银证券此前已将公司评级从“买入”下调至“中性”，目标价定为79美元，这对市场情绪形成进一步压制。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165651871","title":"异动解读｜Liquidia Technologies盘中下跌5.12%，Q2业绩高增但EPS未达部分机构预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1165651871","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165651871?lang=zh_cn&edition=full","pubTime":"2026-08-13 00:35","pubTimestamp":1786552525,"startTime":"0","endTime":"0","summary":"8月13日，Liquidia Technologies盘中下跌5.12%，报83.545美元/股，成交额1.39亿美元。消息面上，公司于8月12日盘前发布第二季度财报，Q2实现每股收益0.74美元，较去年同期亏损0.49美元大幅扭亏；营收1.717亿美元，同比增长约18.5倍，核心产品YUTREPIA净销售额约1.704亿美元，环比增长31%，独立患者处方数约5,900人。尽管营收超出市场一致预期的1.685亿美元，但EPS未达FactSet预期的0.76美元，叠加此前股价已充分反映高增长预期，市场出现获利回吐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150680357","title":"财报前瞻 ｜Liquidia Technologies Inc本季度营收预计增40.67%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1150680357","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150680357?lang=zh_cn&edition=full","pubTime":"2026-08-05 08:24","pubTimestamp":1785889445,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc将于2026年08月12日发布最新季度财报，围绕新一代吸入式治疗产品的放量与商业化推进成为市场关注重点。市场一致预期本季度Liquidia Technologies Inc营收为1.69亿美元，同比增40.67%；预计调整后每股收益为0.74美元，同比增272.32%；预计息税前利润为7,428.59万美元，同比增303.08%。上季度Liquidia Technologies Inc实现营收1.33亿美元，同比增41.58%；毛利率91.08%；归属于母公司股东的净利润为5,286.20万美元，净利率39.79%，调整后每股收益0.52美元，同比增115.56%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Liquidia Technologies Inc本季度营收预计增40.67%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149333279","title":"异动解读｜Liquidia Technologies盘中上涨5.41%，报88.475美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149333279","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149333279?lang=zh_cn&edition=full","pubTime":"2026-08-05 00:17","pubTimestamp":1785860274,"startTime":"0","endTime":"0","summary":"8月5日，Liquidia Technologies盘中上涨5.41%，报88.475美元/股，成交额3513.56万美元。Liquidia Technologies所在的制药行业中，个股中，礼来涨0.49%，辉瑞涨2.18%，阿斯利康跌0.16%，强生跌0.76%，默沙东涨0.74%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。其核心产品YUTREPIA一季度净产品销售额约1.3亿美元，当季EPS为0.52美元，公司下一次财报预计于8月12日发布，市场预期EPS为0.70美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127961968","title":"异动解读｜Liquidia Technologies盘前上涨5.57%，报90.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127961968","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127961968?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150085,"startTime":"0","endTime":"0","summary":"7月27日，Liquidia Technologies盘前上涨5.57%，报90.00美元/股，成交额16.06万美元。Liquidia Technologies所在的制药行业中，个股中，礼来涨0.25%，强生涨0%，默沙东跌0.28%，施贵宝涨0.34%，辉瑞涨0.08%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181056163","title":"异动解读｜Liquidia盘中上涨6.8%，报86.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181056163","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181056163?lang=zh_cn&edition=full","pubTime":"2026-07-22 23:39","pubTimestamp":1784734753,"startTime":"0","endTime":"0","summary":"7月22日，Liquidia盘中上涨6.8%，报86.25美元/股，成交额5282.27万美元。Liquidia所在的制药行业中，个股中，礼来跌0.8%，强生涨1.96%，默沙东涨1.83%，辉瑞涨0.48%，诺和诺德跌1.27%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184282530","title":"异动解读｜Liquidia盘中上涨5.05%，报79.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184282530","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184282530?lang=zh_cn&edition=full","pubTime":"2026-07-18 01:03","pubTimestamp":1784307828,"startTime":"0","endTime":"0","summary":"7月18日，Liquidia盘中上涨5.05%，报79.07美元/股，成交额4194.29万美元。Liquidia所在的制药行业中，整体表现偏强，个股中，礼来涨0.84%，强生涨1.23%，默沙东涨0.25%，辉瑞跌0.12%，施贵宝涨0.83%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130088418","title":"异动解读｜Liquidia盘中上涨5.21%，报74.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130088418","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130088418?lang=zh_cn&edition=full","pubTime":"2026-07-14 23:40","pubTimestamp":1784043603,"startTime":"0","endTime":"0","summary":"7月14日，Liquidia盘中上涨5.21%，报74.92美元/股，成交额2232.96万美元。Liquidia所在的制药行业中，整体表现偏弱，个股中，礼来跌2.46%，强生跌1.78%，辉瑞跌1.16%，默沙东跌2.38%，阿斯利康跌2.13%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106432202","title":"异动解读｜Liquidia盘中下跌8.52%，投行下调评级与董事密集减持持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106432202","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106432202?lang=zh_cn&edition=full","pubTime":"2026-07-14 00:15","pubTimestamp":1783959358,"startTime":"0","endTime":"0","summary":"7月14日，Liquidia盘中下跌8.52%，报71.19美元/股，成交额7567.27万美元。消息面上，美银证券此前将Liquidia评级从\"买入\"下调至\"中性\"，目标价79美元。与此同时，公司董事Bloch Stephen M自6月至7月初累计卖出超30万股，套现金额超2200万美元，频繁的内部人减持进一步加剧市场抛压。当前股价已大幅跌破美银目标价，较7月10日收盘价77.93美元继续下行，显示评级下调与高管减持的负面效应仍在发酵，市场情绪持续偏弱。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170534184","title":"异动解读｜Liquidia盘中下跌5.66%，投行下调评级叠加董事密集减持承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1170534184","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170534184?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:21","pubTimestamp":1783693317,"startTime":"0","endTime":"0","summary":"7月10日，Liquidia盘中下跌5.66%，报76.84美元/股，成交额2070.57万美元。消息面上，美银证券此前将Liquidia评级从\"买入\"下调至\"中性\"，目标价79美元。与此同时，公司董事Bloch Stephen M近期持续大规模减持，仅6月至7月初累计卖出超30万股，套现金额超2200万美元，频繁的内部人减持进一步加剧市场抛压。当前股价已跌破美银目标价，显示市场情绪偏弱。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117263612","title":"异动解读｜Liquidia Technologies盘中上涨5.07%，评级下调超跌后反弹逼近目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1117263612","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117263612?lang=zh_cn&edition=full","pubTime":"2026-07-01 00:21","pubTimestamp":1782836516,"startTime":"0","endTime":"0","summary":"6月30日，Liquidia Technologies盘中上涨5.07%，报78.93美元/股，成交额3370.43万美元。消息面上，此前一交易日美银证券将公司评级从\"买入\"下调至\"中性\"，目标价设定为79美元，引发获利回吐导致股价一度跌逾5%至73美元附近。当前股价反弹至接近目标价水平，显示市场消化评级调整后的估值修复。基本面方面，公司一季度EPS 0.52美元，超预期的0.41美元，核心产品YUTREPIA净产品销售额约1.3亿美元，同比扭亏为盈，独立患者处方超4500份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138967241","title":"异动解读｜Liquidia Technologies盘中下跌5.37%，美银证券下调评级至中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1138967241","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138967241?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:09","pubTimestamp":1782742182,"startTime":"0","endTime":"0","summary":"6月29日，Liquidia Technologies盘中下跌5.37%，报73.01美元/股，成交额3070.31万美元。消息面上，美银证券将Liquidia评级从\"买入\"下调至\"中性\"，目标价设定为79美元。此前该股因YUTREPIA商业化放量及学术会议催化一度在盘前走高，但评级下调引发获利回吐压力。一季度公司实现EPS 0.52美元，超市场预期的0.41美元，净产品销售额约1.3亿美元，同比扭亏为盈。尽管基本面强劲，投行下调评级或暗示当前估值已充分反映利好，短期上行空间受限。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128215928","title":"异动解读｜Liquidia Technologies盘前上涨5.96%，YUTREPIA商业化势头强劲叠加学术会议催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1128215928","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128215928?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:02","pubTimestamp":1782720161,"startTime":"0","endTime":"0","summary":"6月29日，Liquidia Technologies盘前上涨5.96%，报80.97美元/股，成交额5.01万美元。消息面上，公司核心产品YUTREPIA商业化持续放量，一季度净产品销售额约1.3亿美元，超4500份独立患者处方，同比实现扭亏为盈（EPS 0.52美元，远超市场预期的0.41美元）。此外，公司于6月11日宣布将在PHA 2026国际肺动脉高压大会上发布海报数据，学术会议催化叠加业绩高增长预期，持续推升市场情绪。一季度业绩公布后，多家分析师上调目标价。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138192096","title":"异动解读｜Liquidia Technologies夜盘上涨6.32%，报83.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138192096","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138192096?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:21","pubTimestamp":1782714114,"startTime":"0","endTime":"0","summary":"6月29日，Liquidia Technologies夜盘上涨6.32%，报83.11美元/股，成交额11.53万美元。Liquidia Technologies所在的制药行业中，个股中，礼来涨1.65%，强生跌0.18%，默沙东跌0.05%，Axsome Therapeutics涨0%，辉瑞涨0%。Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前重点为肺动脉高压治疗。公司核心产品YUTREPIA已实现商业化，最新季度净产品销售额约1.3亿美元，患者处方数持续增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134348790","title":"异动解读｜Liquidia Technologies盘中上涨5.18%，报74.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134348790","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134348790?lang=zh_cn&edition=full","pubTime":"2026-06-23 00:49","pubTimestamp":1782146976,"startTime":"0","endTime":"0","summary":"6月23日，Liquidia Technologies盘中上涨5.18%，报74.73美元/股，成交额7319.12万美元，股价突破此前52周高点73.22美元，创历史新高。Liquidia Technologies所在的制药行业中，个股表现分化，其中Definium Therapeutics涨50.84%，诺和诺德涨7.38%，礼来涨1.29%，强生涨1.21%，辉瑞跌0.42%。Liquidia Corporation是一家生物制药公司，专注于肺动脉高压治疗领域，通过专有的PRINT粒子工程技术平台进行新产品的研发与商业化，该技术能够精确生产均匀的药物颗粒，应用于吸入疗法、疫苗、生物制剂等多种给药途径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.5815},{"period":"1month","weight":-0.589},{"period":"3month","weight":-0.6371},{"period":"6month","weight":-0.2399},{"period":"1year","weight":0.3078},{"period":"ytd","weight":-0.1696}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liquidia Corporation于2020年6月17日在特拉华州成立。该公司是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。该公司通过两家全资子公司Liquidia Technologies和Liquidia PAH作为单一实体运营。该公司通过应用心肺疾病方面的专业知识和专有的PRINT技术进行新产品的研究、开发和制造，PRINT技术是一种粒子工程平台，能够精确生产均匀的药物颗粒，旨在提高广泛疗法的安全性、有效性和性能。通过与第三方的产品开发和研究，该公司拥有将PRINT应用于多种给药途径和药物有效载荷的经验，包括吸入疗法、疫苗、生物制剂、核酸和眼科植入物等。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012167},{"month":4,"riseRate":0.375,"avgChangeRate":-0.058158},{"month":5,"riseRate":0.875,"avgChangeRate":0.19539},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029487},{"month":7,"riseRate":0.375,"avgChangeRate":0.004032},{"month":8,"riseRate":0.444444,"avgChangeRate":0.021851},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.017529},{"month":10,"riseRate":0.555556,"avgChangeRate":0.01707},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liquidia Technologies Inc(LQDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}